Pharma firms upped lobbying 23% before TrumpRx launch
Drug companies involved in TrumpRx increased their lobbying efforts by 23% ahead of the program's launch, spending over $130 million in 2025.
Browsing Tag
medication costs
Cancer Drug Launch Prices Skyrocket Beyond Inflation
Medicare Part D anticancer drugs' launch prices have surged since 2012, even outpacing inflation rates, despite the…